<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_liver" title="Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression" shortTitle="liver" author="Aline Gottlieb, Ali Canbay" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2073-4409/8/11/1358/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
2.	LS	2.
Typical	JJ	typical
Ligands	NNS	ligand
for	IN	for
Bile	NNP	Bile
Acids	NNS	acid
</s>
</head>
<p>
<s type="decl">
BA	NNP	BA
targeted	VBN	target
therapy	NN	therapy
is	VBZ	be
based	VBN	base
on	IN	on
their	PRP$	their
receptors	NNS	receptor
and	CC	and
ligands	NNS	ligand
.	.	.
</s>
<s type="decl">
The	DT	the
regulation	NN	regulation
of	IN	of
BAs	NNP	BAs
on	IN	on
other	JJ	other
pathways	NNS	pathway
occurs	VBZ	occur
mainly	RB	mainly
through	IN	through
the	DT	the
activation	NN	activation
of	IN	of
nuclear	JJ	nuclear
hormone	NN	hormone
receptors	NNS	receptor
(	-LRB-	(
NHRs	NNS	nhr
)	-RRB-	)
such	JJ	such
as	IN	as
the	DT	the
farnesoid	NNP	farnesoid
X	NNP	X
receptor	NN	receptor
(	-LRB-	(
FXR	NNP	FXR
)	-RRB-	)
,	,	,
pregnane	NN	pregnane
X	NNP	X
receptor	NN	receptor
(	-LRB-	(
PXR	NNP	PXR
)	-RRB-	)
,	,	,
and	CC	and
vitamin	NN	vitamin
D	NNP	D
receptor	NN	receptor
(	-LRB-	(
VDR	NNP	VDR
)	-RRB-	)
.	.	.
</s>
<s type="decl">
For	IN	for
the	DT	the
activation	NN	activation
of	IN	of
these	DT	this
receptors	NNS	receptor
,	,	,
it	PRP	it
is	VBZ	be
necessary	JJ	necessary
that	IN	that
they	PRP	they
interact	VBP	interact
with	IN	with
the	DT	the
retinoid	NN	retinoid
X	NNP	X
receptor	NN	receptor
as	IN	as
a	DT	a
heterodimer	NN	heterodimer
(	-LRB-	(
RXR	NNP	RXR
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Afterwards	RB	afterwards
,	,	,
they	PRP	they
act	VBP	act
on	IN	on
various	JJ	various
regulatory	JJ	regulatory
regions	NNS	region
by	IN	by
binding	VBG	bind
to	IN	to
hormone	NN	hormone
response	NN	response
elements	NNS	element
causing	VBG	cause
several	JJ	several
genes	NNS	gene
to	TO	to
be	VB	be
up	RB	up
or	CC	or
downregulated	VBN	downregulate
in	IN	in
their	PRP$	their
transcription	NN	transcription
.	.	.
</s>
<s type="decl">
Most	JJS	most
BAs	NNS	bas
and	CC	and
the	DT	the
secondary	JJ	secondary
BA	NNP	BA
,	,	,
and	CC	and
LCA	NNP	LCA
,	,	,
are	VBP	be
binding	VBG	bind
to	IN	to
FXR	NNP	FXR
and	CC	and
PXR	NNP	PXR
respectively	RB	respectively
.	.	.
</s>
</p>
<head>
<s type="frag">
2.1.	CD	2.1.
FXR	NNP	FXR
</s>
</head>
<p>
<s type="decl">
FXR	NNP	FXR
plays	VBZ	play
an	DT	a
important	JJ	important
role	NN	role
in	IN	in
BA	NN	BA
,	,	,
glucose	NN	glucose
,	,	,
and	CC	and
lipid	NN	lipid
metabolism	NN	metabolism
.	.	.
</s>
<s type="decl">
It	PRP	it
is	VBZ	be
most	RBS	most
highly	RB	highly
expressed	VBN	express
in	IN	in
the	DT	the
liver	NN	liver
,	,	,
ileum	NN	ileum
,	,	,
kidneys	NNS	kidney
,	,	,
and	CC	and
adrenal	JJ	adrenal
glands	NNS	gland
.	.	.
</s>
<s type="decl">
The	DT	the
strongest	JJS	strong
activator	NN	activator
is	VBZ	be
CDCA	NNP	CDCA
,	,	,
followed	VBN	follow
by	IN	by
DCA	NNP	DCA
,	,	,
CA	NNP	CA
,	,	,
and	CC	and
LCA	NNP	LCA
.	.	.
</s>
<s type="sub">
Despite	IN	despite
the	DT	the
fact	NN	fact
that	IN	that
LCA	NNP	LCA
is	VBZ	be
a	DT	a
weak	JJ	weak
activator	NN	activator
of	IN	of
FXR	NNP	FXR
,	,	,
it	PRP	it
is	VBZ	be
a	DT	a
very	RB	very
strong	JJ	strong
downregulator	NN	downregulator
of	IN	of
its	PRP$	its
function	NN	function
and	CC	and
thus	RB	thus
could	MD	could
be	VB	be
termed	VBN	term
a	DT	a
partial	JJ	partial
agonist	NN	agonist
.	.	.
</s>
</p>
<p>
<s type="decl">
Controlling	VBG	control
the	DT	the
synthesis	NN	synthesis
and	CC	and
enterohepatic	JJ	enterohepatic
circulation	NN	circulation
of	IN	of
BAs	NNP	BAs
,	,	,
represents	VBZ	represent
the	DT	the
major	JJ	major
function	NN	function
of	IN	of
FXR	NNP	FXR
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
liver	NN	liver
,	,	,
bile	NN	bile
flow	NN	flow
is	VBZ	be
prompted	VBN	prompt
through	IN	through
FXR	NNP	FXR
activation	NN	activation
.	.	.
</s>
<s type="decl">
After	IN	after
being	VBG	be
activated	VBN	activate
through	IN	through
BA	NNP	BA
in	IN	in
the	DT	the
ileum	NN	ileum
,	,	,
the	DT	the
expression	NN	expression
of	IN	of
fibroblast	NN	fibroblast
growth	NN	growth
factor	NN	factor
15/19	CD	15/19
(	-LRB-	(
FGF15/19	FW	FGF15/19
)	-RRB-	)
increases	VBZ	increase
,	,	,
leading	VBG	lead
to	IN	to
an	DT	a
activation	NN	activation
of	IN	of
fibroblast	NN	fibroblast
growth	NN	growth
factor	NN	factor
receptor	NN	receptor
4	CD	4
(	-LRB-	(
FGFR4	NNP	FGFR4
)	-RRB-	)
in	IN	in
hepatocytes	NNS	hepatocyte
(	:	(
</s>
<figure>
<s type="frag">
Figure	NNP	Figure
1	CD	1
</s>
</figure>
<s type="frag">
)	-RRB-	)
.	.	.
</s>
<s type="decl">
This	DT	this
is	VBZ	be
of	IN	of
great	JJ	great
importance	NN	importance
as	IN	as
FGF15/19	NNP	FGF15/19
is	VBZ	be
an	DT	a
ileum-derived	JJ	ileum-derived
enterokine	NN	enterokine
that	WDT	that
governs	VBZ	govern
BA	NNP	BA
homeostasis	NN	homeostasis
,	,	,
regulates	VBZ	regulate
hepatic	JJ	hepatic
glucose	NN	glucose
metabolism	NN	metabolism
,	,	,
and	CC	and
stimulates	VBZ	stimulate
protein	NN	protein
synthesis	NN	synthesis
.	.	.
</s>
<s type="decl">
If	IN	if
administered	VBN	administer
pharmacologically	RB	pharmacologically
or	CC	or
expressed	VBN	express
transgenically	RB	transgenically
in	IN	in
mice	NNS	mouse
,	,	,
FGF19	NNP	FGF19
increases	VBZ	increase
hepatic	JJ	hepatic
lipid	NN	lipid
oxidation	NN	oxidation
,	,	,
reduces	VBZ	reduce
lipogenesis	NN	lipogenesis
and	CC	and
protects	VBZ	protect
from	IN	from
hepatosteatosis	NN	hepatosteatosis
.	.	.
</s>
<s type="decl">
A	DT	a
lack	NN	lack
of	IN	of
it	PRP	it
causes	VBZ	cause
impaired	JJ	impaired
liver	NN	liver
regeneration	NN	regeneration
.	.	.
</s>
<s type="decl">
A	DT	a
lack	NN	lack
of	IN	of
FGF	NNP	FGF
15	CD	15
results	VBZ	result
in	IN	in
increased	VBN	increase
hepatic	JJ	hepatic
steatosis	NN	steatosis
and	CC	and
in	IN	in
the	DT	the
development	NN	development
of	IN	of
endoplasmic	NN	endoplasmic
reticulum	NN	reticulum
(	-LRB-	(
ER	NN	ER
)	-RRB-	)
stress	NN	stress
in	IN	in
the	DT	the
liver	NN	liver
of	IN	of
mice	NNS	mouse
fed	VBN	fead
a	DT	a
high	JJ	high
fat	JJ	fat
diet	NN	diet
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
activation	NN	activation
of	IN	of
FGFR4	NNP	FGFR4
together	RB	together
with	IN	with
the	DT	the
activation	NN	activation
of	IN	of
small	JJ	small
heterodimer	NN	heterodimer
partner	NN	partner
(	-LRB-	(
SHP	NNP	SHP
)	-RRB-	)
in	IN	in
the	DT	the
liver	NN	liver
,	,	,
inhibits	VBZ	inhibit
CYP7A1	NNP	CYP7A1
.	.	.
</s>
<s type="decl">
In	IN	in
order	NN	order
to	TO	to
downregulate	VB	downregulate
<hi rend="italic">
CYP7A1	NN	CYP7A1
,	,	,
</hi>
intestinal-specific	JJ	intestinal-specific
FXR	NNP	FXR
is	VBZ	be
required	VBN	require
.	.	.
</s>
<s type="decl">
On	IN	on
the	DT	the
other	JJ	other
hand	NN	hand
,	,	,
the	DT	the
liver-specific	JJ	liver-specific
FXR	NNP	FXR
plays	VBZ	play
an	DT	a
important	JJ	important
role	NN	role
in	IN	in
the	DT	the
repression	NN	repression
of	IN	of
the	DT	the
expression	NN	expression
of	IN	of
<hi rend="italic">
CYP8B1	NNP	CYP8B1
</hi>
.	.	.
</s>
</p>
<p>
<s type="decl">
One	CD	one
of	IN	of
the	DT	the
mechanisms	NNS	mechanism
for	IN	for
BAs	NNP	BAs
to	TO	to
suppress	VB	suppress
their	PRP$	their
own	JJ	own
synthesis	NN	synthesis
is	VBZ	be
through	IN	through
FXR	NNP	FXR
.	.	.
</s>
</p>
<p>
<s type="decl">
FXR	NNP	FXR
influences	VBZ	influence
the	DT	the
hepatic	JJ	hepatic
lipid	NN	lipid
homeostasis	NN	homeostasis
via	IN	via
SHP	NNP	SHP
,	,	,
which	WDT	which
reduces	VBZ	reduce
the	DT	the
expression	NN	expression
of	IN	of
SREBP1	FW	SREBP1
.	.	.
</s>
<s type="decl">
It	PRP	it
also	RB	also
regulates	VBZ	regulate
the	DT	the
expression	NN	expression
of	IN	of
peroxisome	NN	peroxisome
proliferator-activated	NN	proliferator-activated
receptor	NN	receptor
PPAR-α	NNP	PPAR-α
,	,	,
a	DT	a
regulator	NN	regulator
of	IN	of
triglyceride	NN	triglyceride
metabolism	NN	metabolism
,	,	,
that	WDT	that
can	MD	can
induce	VB	induce
free	JJ	free
fatty	NN	fatty
acid	NN	acid
β-oxidation	NN	β-oxidation
.	.	.
</s>
</p>
<head>
<s type="frag">
2.2.	CD	2.2.
</s>
<s type="frag">
Takeda	NNP	Takeda
G-Protein-Coupled	NNP	G-Protein-Coupled
Receptor	NNP	Receptor
5	CD	5
(	-LRB-	(
TGR5	CD	TGR5
)	-RRB-	)
</s>
</head>
<p>
<s type="decl">
TGR5	NNP	TGR5
is	VBZ	be
a	DT	a
G-protein	NNP	G-protein
coupled	VBN	couple
membrane	NN	membrane
receptor	NN	receptor
that	WDT	that
BAs	NNP	BAs
activate	VBP	activate
.	.	.
</s>
<s type="decl">
LCA	NNP	LCA
is	VBZ	be
considered	VBN	consider
to	TO	to
be	VB	be
the	DT	the
strongest	JJS	strong
activator	NN	activator
of	IN	of
TGR5	NNP	TGR5
among	IN	among
the	DT	the
main	JJ	main
primary	JJ	primary
and	CC	and
secondary	JJ	secondary
BAs	NNS	bas
.	.	.
</s>
<s type="decl">
It	PRP	it
is	VBZ	be
widely	RB	widely
expressed	VBN	express
in	IN	in
the	DT	the
body	NN	body
,	,	,
for	IN	for
example	NN	example
in	IN	in
the	DT	the
gallbladder	NN	gallbladder
,	,	,
ileum	NN	ileum
,	,	,
colon	NN	colon
,	,	,
liver	NN	liver
(	-LRB-	(
not	RB	not
in	IN	in
hepatocytes	NNS	hepatocyte
though	RB	though
)	-RRB-	)
,	,	,
brown	JJ	brown
adipose	NN	adipose
tissue	NN	tissue
(	-LRB-	(
BAT	NNP	BAT
)	-RRB-	)
,	,	,
nervous	JJ	nervous
system	NN	system
,	,	,
and	CC	and
muscle	NN	muscle
.	.	.
</s>
<s type="decl">
Besides	IN	besides
being	VBG	be
involved	VBN	involve
in	IN	in
BA	NNP	BA
,	,	,
glucose	NN	glucose
,	,	,
and	CC	and
lipid	NN	lipid
metabolism	NN	metabolism
,	,	,
interestingly	RB	interestingly
,	,	,
it	PRP	it
also	RB	also
plays	VBZ	play
a	DT	a
role	NN	role
in	IN	in
increasing	VBG	increase
the	DT	the
induction	NN	induction
of	IN	of
<hi rend="italic">
BAT	NN	BAT
</hi>
expression	NN	expression
in	IN	in
thermogenesis	NN	thermogenesis
and	CC	and
energy	NN	energy
release	NN	release
via	IN	via
browning	NN	browning
of	IN	of
white	JJ	white
adipose	NN	adipose
tissue	NN	tissue
and	CC	and
.	.	.
</s>
<s type="decl">
TGR5	NNP	TGR5
knockout	NN	knockout
leads	VBZ	lead
to	IN	to
a	DT	a
changed	VBN	change
BA	NN	BA
composition	NN	composition
and	CC	and
has	VBZ	have
anti-inflammatory	JJ	anti-inflammatory
properties	NNS	property
by	IN	by
for	IN	for
example	NN	example
by	IN	by
inhibiting	VBG	inhibit
nuclear	JJ	nuclear
factor	NN	factor
kappa-light-chain-enhancer	NN	kappa-light-chain-enhancer
of	IN	of
activated	VBN	activate
B	NN	B
cells	NNS	cell
(	-LRB-	(
NF-κB	NNP	NF-κB
)	-RRB-	)
or	CC	or
LPS-induced	VBN	lPS-induce
production	NN	production
of	IN	of
inflammatory	JJ	inflammatory
cytokines	NNS	cytokine
in	IN	in
macrophages	NNS	macrophage
.	.	.
</s>
<s type="decl">
In	IN	in
another	DT	another
experiment	NN	experiment
,	,	,
TGR5	NNP	TGR5
knockout	NN	knockout
mice	NNS	mouse
received	VBD	receive
a	DT	a
sleeve	NN	sleeve
gastrectomy	NN	gastrectomy
and	CC	and
it	PRP	it
was	VBD	be
shown	VBN	show
how	WRB	how
TGR5	NNP	TGR5
is	VBZ	be
important	JJ	important
in	IN	in
order	NN	order
to	TO	to
decrease	VB	decrease
hepatic	JJ	hepatic
steatosis	NN	steatosis
,	,	,
improve	VB	improve
glucose	NN	glucose
control	NN	control
,	,	,
and	CC	and
increase	VB	increase
the	DT	the
energy	NN	energy
expenditure	NN	expenditure
post-surgery	NN	post-surgery
.	.	.
</s>
</p>
</text>